Even though EphA2 receptors’ regulatory functions in GBM tumourigenesis remain limited, knowing that the ability to knock down GSC self-renewal and tumourigenic capabilities exists via modulation of EphA2 expression is intriguing (27). This evidence concerns the gene EPHA2 and glioblastoma.